Observation of the Natural Course of Age-related Macular Degeneration

Status Not yet recruiting

Clinical Trial Summary

This research will study natural course of dry AMD in Chinese population, screen fundus imaging indicators for patients with Chinese dry AMD, describe the clinical features of Chinese patients with dry AMD, and obtain a biological sample library of dry AMD mainly in China.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Dry Age-related Macular Degeneration
Geographic Atrophy
Macular Degeneration
Macular Degeneration, Dry

Clinical Trial Details

NCT number	NCT05418231
Study type	Observational
Source	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Contact	Junran Sun, M.D.
Phone	+8613661995933
Email	emiliesun@sina.com
Status	Not yet recruiting
Phase
Start date	July 2022
Completion date	July 2027

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03046407` - Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells	Phase 1/Phase 2
Active, not recruiting	`NCT04566445` - HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005	Phase 2
Recruiting	`NCT04339764` - Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration	Phase 1/Phase 2
Active, not recruiting	`NCT05536752` - QA102 Phase II Study in Subjects With Dry AMD	Phase 2
Recruiting	`NCT06351605` - A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT)
Active, not recruiting	`NCT04065490` - Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)	N/A
Recruiting	`NCT06229665` - Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)	Phase 2/Phase 3
Completed	`NCT01002950` - Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy	Phase 2
Active, not recruiting	`NCT03333954` - Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration	N/A
Completed	`NCT05667688` - Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85	Phase 1
Completed	`NCT01379560` - A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration	Phase 2
Completed	`NCT03144999` - Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59	Phase 1
Withdrawn	`NCT04511936` - Microcurrent Stimulation for Dry Age-related Macular Degeneration	N/A
Withdrawn	`NCT04358471` - Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)	Phase 2
Terminated	`NCT04643886` - A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration	Phase 2
Recruiting	`NCT00926861` - Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD	N/A
Active, not recruiting	`NCT04437368` - EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005	Phase 2
Active, not recruiting	`NCT03894020` - GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)
Not yet recruiting	`NCT04875234` - Vision Improvement for Legally Blind Dry AMD Patients
Recruiting	`NCT02755428` - Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration Diseases	Phase 1/Phase 2